Back to Search
THOMAS RATLIFF, MD
MD
Hematology & Oncology Physician
NPI: 1639170665IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
31689(TN)14362(MS)E3185(AR)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Class of 1987
Research & Publications (20)
Early microrecanalization of vas deferens following biodegradable graft implantation in bilaterally vasectomized rats.
PMID 19349949·Asian J Androl·2009
7-preclinical
The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity.
PMID 17786441·Cancer Immunol Immunother·2008
7-preclinical
Involvement of growth factors in the process of post-vasectomy micro-recanalization.
PMID 18006005·J Urol·2008
7-preclinical
Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes.
PMID 18180380·Blood·2008
7-preclinical
Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge.
PMID 18256321·Blood·2008
7-preclinical
Systemic and cell-specific immune response to laparoscopic and open nephrectomy in porcine model.
PMID 18177243·J Endourol·2008
4-observational
Prostate inflammation and its potential impact on prostate cancer: a current review.
PMID 17955503·J Cell Biochem·2008
6-review
Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles.
PMID 18198347·Blood·2008
7-preclinical
Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist.
PMID 18025166·J Immunol·2007
7-preclinical
The role of platelet CD154 in the modulation in adaptive immunity.
PMID 17917065·Immunol Res·2007
6-review
Clinical protocol: phase I study of an adenovirus/prostate-specific antigen vaccine in men with metastatic prostate cancer.
PMID 16454655·Hum Gene Ther·2006
8-other
Induction of protective immunity to RM-1 prostate cancer cells with ALVAC-IL-2/IL-12/TNF-alpha combination therapy.
PMID 16991124·Int J Cancer·2006
7-preclinical
T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction.
PMID 16388504·Prostate·2006
7-preclinical
Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells.
PMID 16423061·Immunology·2006
7-preclinical
Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
PMID 16217397·J Urol·2005
8-other
CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomas.
PMID 16217398·J Urol·2005
4-observational
EGO-1, a putative RNA-dependent RNA polymerase, is required for heterochromatin assembly on unpaired dna during C. elegans meiosis.
PMID 16271877·Curr Biol·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7945 WOLF RIVER BLVD
GERMANTOWN, TN 38138 - Phone
- (901) 683-0055
Quick Facts
- NPI
- 1639170665
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile